Chambal Fertilisers reported a 5% decline in consolidated net profit to ₹523.6 crore for Q1 FY27, compared to ₹550 crore in the same quarter of the previous year. According to Trade Brains, this profit decline occurred despite the company achieving strong revenue growth during the quarter. The company's consolidated operating income came in at ₹5,027 crore, down 12% year on year, mainly due to lower urea volumes caused by planned and extended shutdown of urea plants.
Despite the revenue decline, Chambal demonstrated resilience with EBITDA actually rising 12% to ₹850.8 crore and margins expanding nicely during the quarter. As per Trade Brains, the company's standalone profit was up 10% to ₹703.5 crore, showing better performance on a standalone basis. The revenue dip was primarily attributed to lower urea volumes, with the IMACID joint venture posting a loss due to sulphur shortages and high prices, forcing a prolonged shutdown.
The company's consolidated EBITDA margin stood at 16.92% for the quarter, significantly higher than 13.36% a year ago, according to Trade Brains. Additionally, PAT margin on a consolidated basis was close to 10.42%. Chambal remains the country's largest private sector urea maker with about 10% market share and 3.4 MMTPA of urea capacity across three plants in Gadepan, Rajasthan, with urea alone making up 57% of its Q1 FY27 revenue.
Chambal's shares were trading at ₹455 per share, closing up 3.61% from the previous close, with a market capitalization of ₹18,230. Meanwhile, Paradeep Phosphates closed at ₹145, down 1.56% with a market capitalization of ₹15,059. As per Trade Brains, Chambal comes across as the more margin-disciplined business with a strong balance sheet and near-zero debt, while Paradeep is showing sharper top line momentum backed by its backward integration story.
